Morphological sex differences in adults can result from differential gonadal steroid exposure during critical perinatal periods. This study describes the use of a monoclonal antibody we have developed to study mechanisms of sexual differentiation of brain structure and function. Used as a marker in immunocytochemistry, antibody AB-2 revealed subsets of cells, including radial glia, transiently during the perinatal period. Peak reactivity in radial glia was on embryonic day 19 in males and on postnatal day 1 in females. On postnatal day 1, AB-2 immunoreactivity in radial glia was 2-fold greater in females than in males. Greater activity was detected in males on one side of the brain than the other (2-to 4-fold, depending on the region). To test the hormone dependence of this sex difference, pregnant rats were injected with testosterone propionate to expose fetal females to androgen on embryonic day 18. This resulted in lower levels of AB-2 immunoreactivity in radial glia of the treated female offspring on postnatal day 1 relative to control females, and the pattern was bilaterally asymmetric, approaching that of males. Thus the difference between sexes in immunoreactivity with AB-2 as a marker was hormone dependent in a predictable manner. Whether this marker is revealing a sex difference in accessibility of antigen by immunocytochemistry or a sex difference in intrinsic antigen levels is not yet resolved. In either case these results support the hypothesis that certain hormone-dependent molecular events occur transiently during development.
ABSTRACT
Morphological sex differences in adults can result from differential gonadal steroid exposure during critical perinatal periods. This study describes the use of a monoclonal antibody we have developed to study mechanisms of sexual differentiation of brain structure and function. Used as a marker in immunocytochemistry, antibody AB-2 revealed subsets of cells, including radial glia, transiently during the perinatal period. Peak reactivity in radial glia was on embryonic day 19 in males and on postnatal day 1 in females. On postnatal day 1, AB-2 immunoreactivity in radial glia was 2-fold greater in females than in males. Greater activity was detected in males on one side of the brain than the other (2-to 4-fold, depending on the region). To test the hormone dependence of this sex difference, pregnant rats were injected with testosterone propionate to expose fetal females to androgen on embryonic day 18. This resulted in lower levels of AB-2 immunoreactivity in radial glia of the treated female offspring on postnatal day 1 relative to control females, and the pattern was bilaterally asymmetric, approaching that of males. Thus the difference between sexes in immunoreactivity with AB-2 as a marker was hormone dependent in a predictable manner. Whether this marker is revealing a sex difference in accessibility of antigen by immunocytochemistry or a sex difference in intrinsic antigen levels is not yet resolved. In either case these results support the hypothesis that certain hormone-dependent molecular events occur transiently during development.
An increasing number of experiments have indicated sex differences in neural morphology discernible in adult brains in virtually all species examined (reviewed in refs. 1 and 2). In many cases, these sex differences in adult morphological characteristics arise as a result of sex differences in gonadal steroid exposure during critical perinatal periods (e.g., refs. [3] [4] [5] . However, the molecular mechanisms by which gonadal steroids induce sex-specific differences in the developing
brain have yet to be elucidated (6) (7) (8) .
To identify and characterize developmentally important molecules during the critical periods of sexual differentiation, we are generating monoclonal antibodies against homogenates of neonatal rat hypothalamus. We are using these markers to test several hypotheses about the mechanisms of sexual differentiation of brain structure and function. One of these is that specific hormone-dependent molecular events occur transiently early in development with long-term sexselective consequences. Antibody AB-2 (9) used in immunocytochemistry (ICC) reveals reactive cellular elements throughout the perinatal period. The antigen(s) recognized is localized in at least one cell type (radial glia) that is known to exist transiently during development (10) . Therefore, we have focused attention on the time course of expression of AB-2 antigens detected by this monoclonal antibody, comparing the temporal pattern of immunocytochemical expression in males and females.
Significant sex differences in endocrine factors such as plasma testosterone concentrations (11) and brain aromatase activity (12, 13) are prominent at specific times during development. In this study we characterized the sex differences in the expression of AB-2 immunoreactivity in the hypothalamus and tested its hormone dependence. AB-2-immunoreactive radial glia were examined after exposing genetic females to testosterone on embryonic day 18 (E18), a time when males and females normally are exposed to different levels of androgen (11) .
MATERIALS AND METHODS
Monoclonal Antibody AB-2. Recipient BALB/c mice (60-day-old females; Charles River Breeding Laboratories, Wilmington, MA) were injected first with homogenates of hypothalamus and temporal cortex from postnatal day 4 (P4) female Sprague-Dawley rats (Charles River Breeding Laboratories). To increase the probability of an immune response selective for antigens differing quantitatively or qualitatively in males and females, these mice were also administered the immunosuppressant cyclophosphamide [100 mg/kg of body weight; 2 mg/0.5 ml of saline (14) ] 0, 24, and 48 hr after the injection of homogenate from female donors. Two weeks later these mice were immunized with homogenate from P4 male rat hypothalamus and temporal cortex. After repeating this entire 2-week sequence three times, hybridomas were produced and subcloned according to standard procedures (15) (3 dorsal/ventral X 2 left/right) were summed for each animal (maximum score is therefore 3 x 2 x 4 = 24). To estimate the degree of asymmetry, the ratings from each side of the brain were summed at each level and the ratio of high side rating to low side rating was calculated for each animal. A section symmetrical for AB-2 immunoreactivity would have a ratio of 1. RESULTS AB-2 immunoreactivity was revealed by the presence of reaction product in several morphological elements, including both neuronal and glial cell types. The extent and intensity of immunoreactivity and the regional distribution were dependent on age. One prominent type of immunopositive element observed was radial processes. These were evident at the earliest age studied (E19) and extended unbranched from the wall of the third ventricle of the pial surface at the base of the brain (Fig. 1) , where conical endfeet were observed. In general, the largest number of radial processes in the hypothalamus were apparent caudal to the optic chiasm, with a consistently large number throughout the length of the bilateral arcuate nucleus in the ventral region of the third ventricle. Immunopositive radial processes were also noted in other brain regions, including the septum, striatum, and regions of cortex. From E19 to P4 these cells/processes conformed to criteria for radial glial cells (23) (24) (25) . Beginning at P4, and into the second postnatal week, AB-2-immunoreactive radial processes in the hypothalamus traversed shorter distances and were more restricted in their distribution, primarily in caudal regions in the ventral half of the third ventricle around the median eminence. These processes in older animals appeared less as radial glia and more as a subset of the class of cells commonly called tanycytes (25) .
A second type of immunoreactive element observed was neuronal and/or glial cell bodies. The greatest number of cell bodies were observed on P4 in the preoptic area and hypothalamus. These immunopositive cells were on both sides of the ventral half ofthe third ventricle, from the rostral preoptic area to the level of the arcuate nuclei in the medial basal hypothalamus. More caudally, in the ventromedial nucleus, the region of highest cellular immunoreactivity extended beyond the ventrolateral border of the nucleus (not shown).
Within specific regions of the preoptic area and hypothalamus, the age-dependent detectability of radial glia with the AB-2 monoclonal antibody differed between males and females. Among males the maximal AB-2 immunoreactivity in radial glia was apparent on E19, whereas in females the maximal immunoreactivity was apparent on P1 (Fig. 2) . The largest sex differences were apparent in regions spanning the caudal preoptic area to the rostral median eminence. This is &~16 .6 8 4 just caudal to the sexually dimorphic nucleus of the preoptic area (26) and coincident with the rostral portion of the ventromedial nucleus of the hypothalamus. On P1, at these levels, significantly more processes were apparent in females than males (Figs. 1 and 3) .
A striking feature of the sex difference observed on P1 was the frequency and extent of asymmetrical AB-2 immunoreactivity. Asymmetrical patterns of immunoreactivity were more frequent and extensive in males than females (Figs. 1  and 4) . The asymmetry was restricted primarily to sections that lie caudal to the midpoint of the optic chiasm, running caudally as far as the rostral arcuate nucleus/median eminence region. The asymmetry was most apparent at middle and dorsal levels of the third ventricle rather than ventral locations, although the asymmetry was apparent at all ventral-dorsal levels in the region of the caudal optic chiasm. In instances where the side of the brain was positively identified as left or right, higher densities of AB-2-immunoreactive radial glia were almost always noted on the right side of the brain (8/9 on P1; 4/4 on E21). This was also true in the few females that were asymmetric on either E21 or P1.
The asymmetric immunoreactivity seen with AB-2 in radial glia was not seen in features revealed by other antibodies. Antibody 3D10 served as one control for the secondary antibody, since no elements were immunopositive in the E19, E21, and P1 hypothalamus, the same as obtained either without primary or without secondary antibodies. However, putative tanycytes were immunopositive using 3D10 in the hypothalamus at P4 and older. Under the conditions used, glial filamentous protein immunoreactivity was restricted to a subset of radial glia in the ventral hypothalamus ofmale and female rats, and these were generally symmetric in both sexes. Antibodies directed against microtubule-associated protein 2 or transferrin revealed perikaryal immunoreactivity in the hypothalamus at perinatal ages and did not appear sex-dependent. Experiments with other antibodies that also recognize subsets ofradial glia are necessary to determine the relationship of A13-2-immunoreactive radial glia to the total population of radial glia in the diencephalon.
Effect of Prenatal Androgen Treatment. Treatment of females with TP on E18 lowered ratings of AB-2 immunoreactivity in radial glia on P1 relative to control females (Figs.  3 and 5) . Furthermore, the immunoreactive pattern was asymmetric in restricted rostral-caudal planes, approaching the male pattern (Figs. 4 and 5) . In contrast, when similarly TP injected females were examined at E21, the number of AB-2-immunoreactive radial glia cells was not significantly different from that of control females or males (not shown).
DISCUSSION
Experiments performed with antibody AB-2 allow us to begin examining the timing of molecular changes during the critical period of sexual differentiation of the brain. We are testing the hypothesis that events leading to the maturation ofcertain sexual dimorphisms in adults involve sex-dependent expression, under gonadal hormone control, of a transient class of molecules during specific developmental periods. The first step in this approach is to determine if sex differences occur The perinatal period is one of rapid and extensive change for AB-2 immunoreactivity in cells and processes in the rat hypothalamus. Ages of maximal immunoreactivity were earlier for radial glia processes (E19-P1) than for cell bodies (P4). For radial processes the peak period ofAB-2 immunoreactivity was earlier for males (E19) than females (P1). Thus, AB-2 immunoreactivity provides a sex-dependent marker for the timing during development ofthe expression ofantigen(s) contained in specific elements in the developing hypothalamus.
The results of the present study indicate that the timing of certain developmental events differs between males and females. We also have shown that prenatal treatment with androgen can account for some aspects of these sex differences in development. Thus, in a specific portion of the hypothalamus an event such as the decrease of a particular marker occurs earlier in males than in females. Sex differences in the time course of specific molecular events may alter the potential for subsequent developmental steps (27) and in a cascading fashion result in stable sexual dimorphisms (28 (29) . The undetermined mechanism(s) for this difference also may affect other measures such as those reported here. We have yet to determine whether the amount of AB-2 antigen differs by sex and brain side or whether the accessibility or stability of antigen differs by sex and brain side.
An unexpected result in the present study is the large degree of asymmetry in AB-2 immunoreactivity. Transient morphological asymmetries have been described in other brain regions, including parts of rat cortex (30, 31) and chick medial habenula (32) . As in our study, in the case of the medial habenula the greater degree of asymmetry in male chicks was also demonstrated in developing females that received exogenous testosterone (32) . Asymmetric functional responses to exogenous androgen have also been reported. Unilateral implantation of gonadal steroids in the hypothalamus and preoptic area of neonatal (33) and adult (34) rats caused differential behavioral effects, dependent on the brain side of the implant. The results in our study may indicate an anatomical and biochemical locus for the generation of functional differences.
Two separate models could account for the observed asymmetry in immunoreactivity. (i) The two sides of the hypothalamus might be developing at different rates (33, 35) . They might undergo qualitatively similar changes but with different temporal patterns. (ii) The two sides might be intrinsically different if one side contains elements not present in the other.
The region of hypothalamus in which AB-2 immunoreactivity is sex-dependent becomes sexually dimorphic in several ways by adulthood. AB-2 immunoreactivity is seen in radial glia during the period when neuronal migration occurs in the hypothalamus/preoptic area (36, 37) . Hormonally influenced radial glia could play a developmental role (38) by directing the migration of neurons or their processes (23, 39) . Sex dependence has been noted in the cell density of the anterior hypothalamic area (40) and in the volume of the bed nucleus of the stria terminalis [BST (41, 42) ] and the ventromedial nucleus of the hypothalamus (43) . Sex differences in connectivity ofcells in the hypothalamus or BST have been suggested by electrophysiological studies (44) , Golgi studies (45, 46) , and the examination of other fiber systems for known neurotransmitters [e.g., serotonin (47), substance P (48)].
It has been suggested that certain developmental markers appear earlier in human females than in males because of growth-suppressive effects of testosterone (49) . Though the results in our study of rats do not test this hypothesis, it raises some additional considerations. Androgens in normal male fetuses could alter rates of postnatal development either by accelerating or retarding particular embryonic events. For example, a hormonal response early in development may alter the molecular and cellular substrate for potential genetic and experimental effects later in development. Retardation at the later ages could be caused by lower numbers of available targets as a result of early hormone exposure. These targets could be less available either because an earlier event ceased more quickly in response to hormone or because an earlier event was delayed, thus leading to later maturation of the target. In extrapolating from knowledge of putative sex differences in cortical function (50) , accurate predictions about hormonal influences will benefit from further definition of the early molecular events in sexual differentiation.
